GSK's R&D in HIV enabled the treatment of around 21 Million adults and children

GSK's R&D in HIV enabled the treatment of around 21 Million adults and children
Unsplash Photo by Diana Polekhina
Written by
User profile picture Abdulmajeed V. Jan 3rd, 2024
Reviewed by
Luca L.

Register to read the full analysis —or— Upgrade to access more features

#HIV #drug #WHO #R&D #vaccine

Assess the impact materiality of this Topic for GlaxoSmithKline

How negative/positive is the impact of GlaxoSmithKline for this Topic?

How would you rate the scale, scope and irremediability of this impact?

Share this Analysis


Written by
User profile picture Abdulmajeed V. Jan 3rd, 2024
Reviewed by
Luca L.

Keen to rectify an issue with this analysis?